DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Mitoquinone is an investigational drug.
There have been 7 clinical trials for Mitoquinone. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2007.
The most common disease conditions in clinical trials are Sclerosis, Multiple Sclerosis, and Fatigue. The leading clinical trial sponsors are Antipodean Pharmaceuticals, Inc., University of Copenhagen, and VA Office of Research and Development.
Recent Clinical Trials for Mitoquinone
|Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle||University of Copenhagen||N/A|
|MitoQ for Fatigue in Multiple Sclerosis (MS)||VA Office of Research and Development||Phase 1/Phase 2|
|MitoQ on Fatigue in Multiple Sclerosis||MitoQ Ltd||Phase 1/Phase 2|